BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22799361)

  • 1. Modeling of breast cancer prognostic factors using a parametric log-logistic model in Fars province, Southern Iran.
    Zare N; Doostfatemeh M; Rezaianzadeh A
    Asian Pac J Cancer Prev; 2012; 13(4):1533-7. PubMed ID: 22799361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in gastric cancer using log-normal censored regression model.
    Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
    Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.
    Nematolahi S; Ayatollahi SMT
    Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
    Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
    Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of accelerated failure time models for breast cancer patients' survival in Kurdistan Province of Iran.
    Karimi A; Delpisheh A; Sayehmiri K
    J Cancer Res Ther; 2016; 12(3):1184-1188. PubMed ID: 28054533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of survival time of breast cancer in kurdistan province of Iran between 2006-2014: a cox regression approach.
    Karimi A; Delpisheh A; Sayehmiri K; Saboori H; Rahimi E
    Asian Pac J Cancer Prev; 2014; 15(19):8483-8. PubMed ID: 25339051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.
    Wen J; Ye F; Huang X; Li S; Yang L; Xiao X; Xie X
    Tumour Biol; 2016 Jun; 37(6):7493-500. PubMed ID: 26678892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Empirical Bayesian Approach.
    Nematolahi S; Rezaianzadeh A; Zare N; Akrami M; Tahmasebi S
    East Mediterr Health J; 2018 Jan; 23(11):721-728. PubMed ID: 29319143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer.
    Iqbal J; Ginsburg O; Giannakeas V; Rochon PA; Semple JL; Narod SA
    Breast Cancer Res Treat; 2017 Jan; 161(1):103-115. PubMed ID: 27796715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Prognostic Factors of Male Breast Cancer in Southern Iran: a LASSO-Cox Regression Approach.
    Shahraki HR; Salehi A; Zare N
    Asian Pac J Cancer Prev; 2015; 16(15):6773-7. PubMed ID: 26434910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival in patients with breast cancer referred to Cancer Research Center in Iran.
    Baghestani AR; Shahmirzalou P; Zayeri F; Akbari ME; Hadizadeh M
    Asian Pac J Cancer Prev; 2015; 16(12):5081-4. PubMed ID: 26163645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
    Morikawa A; Jordan L; Rozner R; Patil S; Boire A; Pentsova E; Seidman AD
    Clin Breast Cancer; 2017 Feb; 17(1):23-28. PubMed ID: 27569275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of breast cancer patients using Cox and frailty models.
    Faradmal J; Talebi A; Rezaianzadeh A; Mahjub H
    J Res Health Sci; 2012 Dec; 12(2):127-30. PubMed ID: 23241526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience.
    Houzé de l'Aulnoit A; Rogoz B; Pinçon C; Houzé de l'Aulnoit D
    Breast; 2018 Feb; 37():80-88. PubMed ID: 29102782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between Cox proportional hazard models and logistic regression on prognostic factors in gastric cancer.
    Moghimi-Dehkordi B; Safaee A; Tabei SZ
    East Afr J Public Health; 2009 Apr; 6 Suppl(1):20-2. PubMed ID: 20084981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
    Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
    Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.